refractory inflammatory bowel diseaseCrohn’s diseaseulcerative colitisinflammatory bowel diseaseperianal diseaserisankizumabvedolizumabinfliximabadalimumabIL-23 inhibitors
…ation of risankizumab and other biologic drugs in patients with refractory inflammatory bowel disease, evaluating its clinical efficacy, progression, and safety prof…